Ghosh Anirvan
SEC insider (Form 3/4/5 filer). CIK 0001807437. Chief Executive Officer at Unity Biotechnology, Inc. (UBX). 5 reported Form 4/5 transactions since Sep 2024; latest on Apr 2, 2025. Located in SOUTH SAN FRANCISCO, CA.
Companies Ghosh Anirvan has filed insider reports for
- Unity Biotechnology, Inc. (UBX): Director, Officer, Chief Executive Officer
Ghosh Anirvan
CIK: 0001807437
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)3 (60.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (40.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
UBX
Unity Biotechnology, Inc.
DirectorOfficer
Discretionary Trading P&L
Holdings
Transaction History (5 total)
- Apr 2, 2025UBX
Unity Biotechnology, Inc.
SaleDirect96.8K shares at avg. $1.03$100K - Mar 28, 2025UBX
Unity Biotechnology, Inc.
AwardDirect175K shares- - Feb 4, 2025UBX
Unity Biotechnology, Inc.
SaleDirect642 shares at avg. $2.23$1K - Jan 22, 2025UBX
Unity Biotechnology, Inc.
AwardDirectStock Option (Right to Buy)
450K shares- - Nov 4, 2024UBX
Unity Biotechnology, Inc.
SaleDirect432 shares at avg. $1.29$557.28
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Apr 2, 2025 | UBX Unity Biotechnology, Inc. | Sale | 96,797 | $1.03 | $99,701 | Direct |
| Mar 28, 2025 | UBX Unity Biotechnology, Inc. | Award | 175,000 | - | - | Direct |
| Feb 4, 2025 | UBX Unity Biotechnology, Inc. | Sale | 642 | $2.23 | $1,432 | Direct |
| Jan 22, 2025 | UBX Unity Biotechnology, Inc. | Award Stock Option (Right to Buy) | 450,000 | - | - | Direct |
| Nov 4, 2024 | UBX Unity Biotechnology, Inc. | Sale | 432 | $1.29 | $557 | Direct |
1-5 of 5 transactions